Summary

Eligibility
for people ages 18-75 (full criteria)
Location
at UC Davis UCSD UCSF
Dates
study started

Description

Summary

The purpose of this study is to find out what effects (good and/or bad) treatment with chemotherapy and stem cell transplant compared with chemotherapy alone will have on primary CNS B-cell lymphoma. Currently the best treatment for patients with primary CNS B-cell lymphoma is not known.

Official Title

A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma

Details

Keywords

Lymphoma, primary central nervous system non-Hodgkin lymphoma, contiguous stage II adult diffuse large cell lymphoma, noncontiguous stage II adult diffuse large cell lymphoma, stage I adult diffuse large cell lymphoma, stage III adult diffuse large cell lymphoma, stage IV adult diffuse large cell lymphoma, Cytarabine, Etoposide, Thiotepa, Carmustine, stem cell transplant, G-CSF

Eligibility

Locations

Details

Status
in progress, not accepting new patients
Start Date
Sponsor
Alliance for Clinical Trials in Oncology
ID
NCT01511562
Phase
Phase 2 Lymphoma Research Study
Study Type
Interventional
Participants
About 113 people participating
Last Updated